首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Survivin as a target for new anticancer interventions
Authors:Zaffaroni Nadia  Pennati Marzia  Daidone Maria Grazia
Institution:Dipartimento di Oncologia Sperimentale, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy. nadia.zaffaroni@istitutotumori.mi.it
Abstract:Survivin is a member of the inhibitor of apoptosis protein (IAP) family, that has been implicated in both control of cell division and inhibition of apoptosis. Specifically, its anti-apoptotic function seems to be related to the ability to directly or indirectly inhibit caspases. Survivin is selectively expressed in the most common human neoplasms and appears to be involved in tumor cell resistance to some anticancer agents and ionizing radiation. On the basis of these findings survivin has been proposed as an attractive target for new anticancer interventions. Several preclinical studies have demonstrated that down-regulation of survivin expression/function, accomplished through the use of antisense oligonucleotides, dominant negative mutants, ribozymes, small interfering RNAs and cyclin-dependent kinase inhibitors, increased the apoptotic rate, reduced tumor-growth potential and sensitized tumor cells to chemotherapeutic drugs with different action mechanisms and gamma-irradiation in in vitro and in vivo models of different human tumor types.
Keywords:Survivin  apoptosis  anticancer drugs  ionizing radiation  antisense oligonucleotides  dominant negative mutants  ribozymes  small interfering RNAs  cycle-dependent kinase inhinitors
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号